Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)

Condition:   Ulcerative Colitis Interventions:   Drug: Remestemcel-L;   Other: Placebo Sponsors:   The Cleveland Clinic;   Mesoblast, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials